You are here

Luye Pharma, owners eye up to US$764m from HK IPO

Drugmaker selling shares after 2012 delisting from SGX

[SINGAPORE] Luye Pharma Group Ltd, a Chinese drugmaker backed by Singapore's sovereign wealth fund, and existing owners are seeking to raise as much as US$764 million from a Hong Kong initial public offering.The company and its investors are selling 999.6 million shares at HK$5.38 to HK$5.92